PositiveID Corporation (OTCQB: PSID) is an emerging growth company that develops biological detection and diagnostic systems for America's homeland defense and the global healthcare market. PositiveID specializes in microfluidic systems for the automated preparation and performance of biological assays in order to detect biological threats and outbreaks whether airborne, in a healthcare setting, or at the point of need.
May 24, 2017
PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics Market
May 23, 2017